This website does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation of any security or any other product or service by MergersUS Inc. or any other third party regardless of whether such security, product or service is referenced in this website. Furthermore, nothing in this website is intended to provide tax, legal, or investment advice and nothing in this website should be construed as a recommendation to buy, sell, or hold any investment or security or to engage in any investment strategy or transaction.
This website is operated by MergersUS Inc.a US Corporation with registered office at 40th Wall Street, Suite #2725, New York, New York 10005, United States of America.
This company for sale is a healthcare company based in Bangalore, India. The business is involved in the manufacturing and supply of medicines and nutritional supplements to people across the globe (Quality standards as specified by WHO-GMP and ISO certifications).
The business is fully equipped ISO 9001 and WHO GMP certified unit is catering to orders from countries like Central America, Nigeria, Bangladesh, Cambodia, Sri Lanka, Malaysia, Dominican Republic etc. The unit has over 50000 square feet of built up area dedicated to production of tablets, capsules and oral liquids.
Company produces Generic, Nutraceuticals and Herbal Medical Products.
Financial Performance Highlights (3 Years)
Revenue has seen a steady increase in the last 3 years but with a reduction in EBITDA. The reduction in EBITDA is due to increased ad spend for an online brand started 5 years ago. Any profit made by this D2C supplements brand is being put back into marketing of the brand which has led to a reduction in EBITDA of the overall company.
Products
438 manufacturing licenses under generic pharmaceuticals. Out of these, company currently holds 148 CoPP approvals which allow us to register our products for export in multiple ROW countries.
Overarching Competitive Advantage
High production capacity for a small scale manufacturing facility with cost advantage. Manufacturing unit located inside the city of Bangalore allows access to both skilled and unskilled labour.
This company for sale is a healthcare company based in Bangalore, India. The business is involved in the manufacturing and supply of medicines and nutritional supplements to people across the globe (Quality standards as specified by WHO-GMP and ISO certifications).
The business is fully equipped ISO 9001 and WHO GMP certified unit is catering to orders from countries like Central America, Nigeria, Bangladesh, Cambodia, Sri Lanka, Malaysia, Dominican Republic etc. The unit has over 50000 square feet of built up area dedicated to production of tablets, capsules and oral liquids.
Company produces Generic, Nutraceuticals and Herbal Medical Products.
Financial Performance Highlights (3 Years)
Revenue has seen a steady increase in the last 3 years but with a reduction in EBITDA. The reduction in EBITDA is due to increased ad spend for an online brand started 5 years ago. Any profit made by this D2C supplements brand is being put back into marketing of the brand which has led to a reduction in EBITDA of the overall company.
Products
438 manufacturing licenses under generic pharmaceuticals. Out of these, company currently holds 148 CoPP approvals which allow us to register our products for export in multiple ROW countries.
Overarching Competitive Advantage
High production capacity for a small scale manufacturing facility with cost advantage. Manufacturing unit located inside the city of Bangalore allows access to both skilled and unskilled labour.
Description
This company for sale is a healthcare company based in Bangalore, India. The business is involved in the manufacturing and supply of medicines and nutritional supplements to people across the globe (Quality standards as specified by WHO-GMP and ISO certifications).
The business is fully equipped ISO 9001 and WHO GMP certified unit is catering to orders from countries like Central America, Nigeria, Bangladesh, Cambodia, Sri Lanka, Malaysia, Dominican Republic etc. The unit has over 50000 square feet of built up area dedicated to production of tablets, capsules and oral liquids.
Company produces Generic, Nutraceuticals and Herbal Medical Products.
Financial Performance Highlights (3 Years)
Revenue has seen a steady increase in the last 3 years but with a reduction in EBITDA. The reduction in EBITDA is due to increased ad spend for an online brand started 5 years ago. Any profit made by this D2C supplements brand is being put back into marketing of the brand which has led to a reduction in EBITDA of the overall company.
Products
438 manufacturing licenses under generic pharmaceuticals. Out of these, company currently holds 148 CoPP approvals which allow us to register our products for export in multiple ROW countries.
Overarching Competitive Advantage
High production capacity for a small scale manufacturing facility with cost advantage. Manufacturing unit located inside the city of Bangalore allows access to both skilled and unskilled labour.
Basic Details
Target Price:
$12,000,000
Gross Revenue
$1,900,000
EBITDA
TBA
Business ID:
L#20210016
Country
India
City:
Bangalore
Detail
Similar Businesses
Published on February 19, 2021 at 3:01 pm. Updated on February 10, 2022 at 10:01 am
Leading Cannabis Producer with Over 100 Franchise Shops Across Europe
€12,500,000
Manufacturing
Aluminum Manufacturing Business
$25,000,000
Manufacturing
Continued Medical Education & Strategic Consulting Organisation
$4,500,000
Medical Businesses, Pharma
30 Year Old International Shipping & Fuel Oil Trading Energy Business
$175,000,000
Manufacturing
Waste Collection Recycling and Recovery Business
€1,600,000
Manufacturing
Motor and Sailing Yachts Manufacturing Business
$25,000,000
Manufacturing, Yatch & Boat Servicing & Repairs
PREVIOUS PROPERTY
Manufacturing & Trading Jewelry Business
NEXT PROPERTY
4 Stars Luxury Beach Hotel Inn & Casino